A. Buraczewska, J. Kardas, B. Młot, W. Solarek, and A. Waśko-Grabowska, “Hypothyroidism caused by cabozantinib therapy of clear cell renal cell carcinoma – case report, own experience”, OncoReview, vol. 7, no. 3(27), pp. 121-125, May 2017.